Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
The Roche Venture Fund was founded in 2002 as an evergreen CVC with a CHF 500M allocation (roughly $850M in AUM). Approximately 40% is currently invested, with the rest available for new opportunities.
The portfolio includes 30+ current companies across 10 countries in Europe, North America, and the Pacific region, with 60+ investments made over the past 20 years. The fund manages all Roche biote...
Similar Funds
Novartis Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Pfizer Ventures
New York, United States
GeneralistBiotechMedTechSeedSeries A
Sanofi Ventures
Paris, France
GeneralistBiotechMedTechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A